TELA

TELA Bio Inc

1.18

Sep 16 • 3:59 PM ET +0.09 (8.26%)

1.22

Aftermarket • 7:56 PM ET +0.04 (3.72%)

Healthcare Medical Devices USA Micro NASD

Peers: ARAY BDMD ECOR ELUT LNSR NSPR SERA LUNG POAS MOBI

| Held by: VTI VXF

Index	-
Market Cap	53.27M
Enterprise Value	79.46M
Income	-41.18M
Sales	79.91M
Book/sh	-0.35
Cash/sh	0.67
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	218
IPO	Nov 08, 2019

P/E	-
Forward P/E	-
PEG	-
P/S	0.67
P/B	-
P/C	1.75
P/FCF	-
EV/EBITDA	-
EV/Sales	0.99
Quick Ratio	2.38
Current Ratio	2.99
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.77
EPS next Y	-0.45
EPS next Q	-0.16
EPS this Y	17.69%
EPS next Y	34.22%
EPS next 5Y	25.04%
EPS past 3/5Y	32.78% 17.97%
Sales past 3/5Y	24.68% 34.54%
EPS Y/Y TTM	30.65%
Sales Y/Y TTM	6.09%
EPS Q/Q	10.29%
Sales Q/Q	-4.49%
Earnings	Aug 10 AMC
EPS/Sales Surpr.	-15.07% -3.59%

Insider Own	27.65%
Insider Trans	0.83%
Inst Own	48.37%
Inst Trans	-5.69%
ROA	-64.71%
ROE	-616.62%
ROIC	-102.40%
Gross Margin	67.81%
Oper. Margin	-42.56%
Profit Margin	-51.53%
SMA20	46.24%
SMA50	51.91%
SMA200	37.25%
Trades

Shs Outstand	44.83M
Shs Float	32.66M
Short Float	1.18%
Short Ratio	2.16
Short Interest	0.38M
52W High	1.68 -29.97%
52W Low	0.50 135.48%
Volatility	12.33% 11.52%
ATR (14)	0.10
RSI (14)	79.77
Beta	1.33
Rel Volume	2.57
Avg Volume	178.02K
Volume	457,144

Perf Week	29.49%
Perf Month	81.54%
Perf Quarter	31.49%
Perf Half Y	46.93%
Perf YTD	0.00%
Perf Year	-25.32%
Perf 3Y	-86.71%
Perf 5Y	-90.73%
Perf 10Y	-
Recom	1.40
Target Price	2.10
Prev Close	1.09
Price	1.18
Change %	8.26%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-21-25	Downgrade	Piper Sandler	Overweight → Neutral	$5 → $2
May-31-22	Initiated	Lake Street	Buy	$17
Dec-03-19	Initiated	Piper Jaffray	Overweight
Dec-03-19	Initiated	JMP Securities	Mkt Outperform
Dec-03-19	Initiated	Jefferies	Buy
Dec-03-19	Initiated	Canaccord Genuity	Buy

Aug-31-26 07:00AM	TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative (GlobeNewswire) +5.43%
Aug-11-26 01:03AM	TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... (GuruFocus.com) -15.05%
Aug-10-26 10:56PM	TELA Bio, Inc. Q2 2026 Earnings Call Summary (Moby) +6.91%
04:05PM	TELA Bio Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-07-26 09:24AM	Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% Upside (GuruFocus.com)
04:05PM	Loading…
Aug-05-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.01%
Aug-04-26 07:00AM	TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director (GlobeNewswire) +22.51%
Jul-29-26 04:05PM	TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-20-26 04:05PM	TELA Bio to Announce Second Quarter 2026 Financial Results (GlobeNewswire)
May-13-26 08:30AM	TELA Bio, Inc. Q1 2026 Earnings Call Summary (Moby) -5.88%
01:01AM	TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ... (GuruFocus.com)
May-12-26 04:05PM	TELA Bio Reports First Quarter 2026 Financial Results (GlobeNewswire) +5.14%
May-11-26 09:23AM	What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings (GuruFocus.com)
May-07-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.11% -7.27%
Apr-30-26 04:43PM	TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues (GlobeNewswire) +13.07%
04:05PM	Loading…
Apr-21-26 04:05PM	TELA Bio to Announce First Quarter 2026 Financial Results (GlobeNewswire)
Mar-25-26 08:30AM	TELA Bio, Inc. Q4 2025 Earnings Call Summary (Moby) -9.35%
Mar-24-26 11:02PM	TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ... (GuruFocus.com) -8.27%
04:05PM	TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-23-26 09:23AM	TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +6.66%
Mar-10-26 04:05PM	TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire) -7.35%
Mar-02-26 08:15AM	Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass Estimates (Zacks)
Feb-26-26 12:15PM	Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-20-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -9.76% +6.77%
Jan-23-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-12-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-19-25 08:30AM	TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) -8.47%
Nov-17-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.08%
Nov-14-25 12:03AM	TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... (GuruFocus.com) -9.97%
Nov-13-25 05:15PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:21PM	Loading…
04:21PM	TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
04:01PM	TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility (GlobeNewswire)
Nov-12-25 08:30AM	Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:36AM	TELA Bio Inc (TELA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-05-25 07:10PM	Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.98%
Nov-04-25 08:30AM	TELA Bio to Announce Third Quarter 2025 Financial Results (GlobeNewswire) -5.84%
Nov-03-25 04:05PM	TELA Bio Appoints William Plovanic to Board of Directors (GlobeNewswire) +11.38%
Oct-09-25 04:05PM	TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran (GlobeNewswire)
Aug-12-25 03:06AM	TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) -13.98%
Aug-11-25 07:00PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +8.14%
04:03PM	TELA Bio Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-08-25 05:00PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:31AM	TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-07-25 09:10AM	Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-06-25 08:15AM	Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -8.11%
Jul-29-25 08:15AM	NeoGenomics (NEO) Meets Q2 Earnings Estimates (Zacks)
Jul-23-25 04:03PM	TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-21-25 04:03PM	TELA Bio to Announce Second Quarter 2025 Financial Results (GlobeNewswire) -7.04%
Jun-07-25 11:01PM	Aroa Biosurgery Ltd (AROAF) (FY25) Earnings Call Highlights: Surpassing Revenue Expectations ... (GuruFocus.com)
Jun-06-25 04:05PM	TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-03-25 04:05PM	TELA Bio Announces European Commercial Launch of OviTex Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair (GlobeNewswire) +10.56% +19.75%
Jun-02-25 08:30AM	TELA Bio Appoints Jeffrey Blizard as President (GlobeNewswire)
May-22-25 04:05PM	TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
May-09-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +9.04% -6.48%
03:41AM	TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges (GuruFocus.com)
May-08-25 05:45PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 11:43AM	TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Apr-21-25 04:28PM	TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... (GuruFocus.com) -6.92% +5.62%
Apr-17-25 04:05PM	TELA Bio to Announce First Quarter 2025 Financial Results (GlobeNewswire)
Mar-31-25 07:00AM	TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex PRS for Plastic and Reconstructive Surgery (GlobeNewswire)
Mar-21-25 02:26PM	TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover (GuruFocus.com) -37.18%
12:05PM	Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result (GuruFocus.com)
Mar-20-25 10:05PM	TELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategy (SeekingAlpha)
10:04PM	TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript (SeekingAlpha)
06:50PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-27-25 04:05PM	TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-21-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-24-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-13-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-19-24 04:05PM	TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference (GlobeNewswire)
Nov-08-24 12:12PM	Q3 2024 TELA Bio Inc Earnings Call (Thomson Reuters StreetEvents)
02:29AM	TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-07-24 06:20PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:49AM	What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings (GuruFocus.com)
Nov-01-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-25-24 09:05PM	OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc (GuruFocus.com) +10.85%
Oct-24-24 04:05PM	TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Oct-23-24 08:07AM	TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +6.43%
Oct-22-24 04:05PM	TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Oct-17-24 04:05PM	TELA Bio to Announce Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-01-24 09:02PM	Orbimed Advisors LLC Reduces Stake in TELA Bio Inc (GuruFocus.com)
Aug-12-24 05:20PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -22.94%
04:05PM	TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance (GlobeNewswire)
Aug-09-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-25-24 04:05PM	TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-22-24 04:05PM	TELA Bio to Announce Second Quarter 2024 Financial Results (GlobeNewswire)
Jun-04-24 04:05PM	TELA Bio Appoints Jeffrey Blizard to its Board of Directors (GlobeNewswire)
May-20-24 04:03PM	TELA Bio Appoints Greg Firestone as Chief Commercial Officer (GlobeNewswire)
May-13-24 11:01AM	TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +16.80%
03:51PM	TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Continued Growth (GuruFocus.com)
10:15AM	Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating (MT Newswires)
May-09-24 04:05PM	TELA Bio Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 04:10PM	MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-25-24 07:00AM	TELA Bio to Announce First Quarter 2024 Financial Results (GlobeNewswire)
Apr-15-24 07:00AM	TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR - Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures (GlobeNewswire)
Apr-08-24 07:00AM	TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy (GlobeNewswire)

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

PresidentMr. Jeffrey Blizard

M.B.A.Ms. Heather C. Getz C.P.A.

VPMs. Megan Smeykal

Chief Technology OfficerMr. Paul Talmo

General Counsel & Corporate SecretaryMr. D. Taylor Ocasio

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Capper Joseph H	Director	Sep 15 '26	Buy	1.06	50,000	52,940	104,827	Sep 16 06:46 PM
Capper Joseph H	Director	Sep 14 '26	Buy	1.02	25,000	25,502	54,827	Sep 16 06:46 PM
Getz Heather C	Chief Executive Officer	Aug 17 '26	Buy	0.66	12,500	8,311	532,500	Aug 19 04:10 PM
Getz Heather C	Chief Executive Officer	Aug 14 '26	Buy	0.70	15,000	10,467	520,000	Aug 17 04:32 PM
EW HEALTHCARE PARTNERS FUND 2,	10% Owner	Nov 17 '25	Buy	1.11	3,604,000	4,000,440	7,714,709	Nov 17 04:26 PM

Open in Screener

MDXG

Mimedx Group Inc

4.73

Sep 16 • 3:59 PM ET +0.01 (0.21%)

4.70

Aftermarket • 5:38 PM ET -0.03 (-0.63%)

Healthcare Biotechnology USA Small NASD

Peers: INCY KYMR BMRN CRNX RYTM VKTX KRYS AXSM MDGL NBIX

| Held by: VTI IWM XBI VXF IWN AVUV VTWO SCHA IWC DFAS

Index	RUT
Market Cap	689.45M
Enterprise Value	570.82M
Income	6.24M
Sales	355.17M
Book/sh	1.48
Cash/sh	0.93
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	808
IPO	Aug 22, 2007

P/E	120.05
Forward P/E	35.30
PEG	-
P/S	1.94
P/B	3.19
P/C	5.08
P/FCF	15.50
EV/EBITDA	27.97
EV/Sales	1.61
Quick Ratio	4.79
Current Ratio	5.33
Debt/Eq	0.08
LT Debt/Eq	0.07
Option/Short	Yes / Yes

EPS (ttm)	0.04
EPS next Y	0.13
EPS next Q	0.00
EPS this Y	-121.88%
EPS next Y	291.43%
EPS next 5Y	-12.19%
EPS past 3/5Y	- -
Sales past 3/5Y	16.05% 11.02%
EPS Y/Y TTM	-80.69%
Sales Y/Y TTM	-2.36%
EPS Q/Q	-255.90%
Sales Q/Q	-34.73%
Earnings	Jul 29 AMC
EPS/Sales Surpr.	-102.02% 1.42%

Insider Own	21.58%
Insider Trans	0.00%
Inst Own	57.63%
Inst Trans	-0.82%
ROA	2.18%
ROE	2.88%
ROIC	2.69%
Gross Margin	78.61%
Oper. Margin	2.46%
Profit Margin	1.76%
SMA20	4.72%
SMA50	8.68%
SMA200	1.98%
Trades

Shs Outstand	145.72M
Shs Float	114.31M
Short Float	8.21%
Short Ratio	7.37
Short Interest	9.38M
52W High	7.97 -40.65%
52W Low	3.03 56.36%
Volatility	3.61% 3.97%
ATR (14)	0.18
RSI (14)	64.18
Beta	1.17
Rel Volume	0.86
Avg Volume	1.27M
Volume	1,094,841

Perf Week	1.07%
Perf Month	12.89%
Perf Quarter	27.84%
Perf Half Y	8.49%
Perf YTD	-30.13%
Perf Year	-32.14%
Perf 3Y	-37.27%
Perf 5Y	-14.31%
Perf 10Y	-47.91%
Recom	1.00
Target Price	7.40
Prev Close	4.72
Price	4.73
Change %	0.21%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-23-26	Initiated	Citizens	Mkt Outperform	$10
Jul-02-24	Initiated	Cantor Fitzgerald	Overweight	$11
Mar-07-24	Initiated	Lake Street	Buy	$12
Oct-27-23	Initiated	Craig Hallum	Buy	$12
Oct-13-22	Initiated	Mizuho	Buy	$7
Jul-26-21	Initiated	Northland Capital	Outperform	$23
Mar-19-21	Initiated	H.C. Wainwright	Buy	$20

Sep-08-26 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-30-26 08:30AM	MiMedx Group, Inc. Q2 2026 Earnings Call Summary (Moby)
01:03AM	MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ... (GuruFocus.com)
Jul-29-26 04:46PM	MiMedx: Q2 Earnings Snapshot (Associated Press)
04:07PM	MIMEDX Announces Second Quarter 2026 Operating & Financial Results (GlobeNewswire)
04:01PM	Loading…
04:01PM	MIMEDX to Acquire Sanara MedTech (GlobeNewswire)
Jul-28-26 09:49AM	Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside (GuruFocus.com)
Jul-20-26 08:00AM	MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29 (GlobeNewswire)
Jun-02-26 09:00AM	The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts (PR Newswire)
May-21-26 08:45AM	MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference (GlobeNewswire)
May-08-26 08:00AM	MIMEDX Announces Launch of G4Derm Plus (GlobeNewswire)
Apr-30-26 03:16AM	MiMedx Group Inc (MDXG) Q1 2026 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) +8.91%
Apr-29-26 04:55PM	MiMedx: Q1 Earnings Snapshot (Associated Press) -9.26%
04:01PM	MIMEDX Announces First Quarter 2026 Operating & Financial Results (GlobeNewswire)
Apr-28-26 09:26AM	MiMedx Group Inc (MDXG) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
08:00AM	Loading…
Apr-22-26 08:00AM	MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29 (GlobeNewswire)
Apr-16-26 08:00AM	MIMEDX Announces Restructuring and Cost Reduction Initiative (GlobeNewswire) -11.60%
Apr-02-26 09:15AM	MIMEDX to Sponsor Leading Advanced Wound Care Conferences (GlobeNewswire)
Mar-23-26 08:00AM	MIMEDX Announces Launch of CHORIOFIX (GlobeNewswire)
Mar-05-26 08:00AM	MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX Thyroid Shields (GlobeNewswire)
Mar-01-26 03:20AM	MiMedx Group (MDXG) Delivers Record Full Year Revenue (Insider Monkey)
Feb-26-26 12:07AM	MiMedx Group Q4 Earnings Call Highlights (MarketBeat) -6.44%
12:05AM	MiMedx Group Inc (MDXG) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-25-26 07:25PM	MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:42PM	MiMedx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results (GlobeNewswire)
Feb-24-26 07:28AM	MiMedx Group Inc (MDXG) Q4 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Feb-17-26 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25 (GlobeNewswire)
Feb-04-26 10:27AM	MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products (GlobeNewswire)
Feb-02-26 03:27PM	Craig-Hallum Adjusts MiMedx Group, Inc. (MDXG) Outlook on CMS Coverage Guidance (Insider Monkey)
08:00AM	Loading…
08:00AM	MIMEDX Celebrates 15 Year Anniversary of EPIFIX and AMNIOFIX (GlobeNewswire)
Dec-22-25 09:43AM	MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit-Wound Gel (GlobeNewswire)
Dec-19-25 09:00AM	MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion Processed Human Amniotic Membrane Allografts In Vitro (GlobeNewswire)
Nov-17-25 09:55AM	MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Nov-13-25 08:00AM	MIMEDX Provides Update on EPIEFFECT Randomized Controlled Trial (GlobeNewswire)
Nov-10-25 04:01PM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-03-25 09:15AM	MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule (GlobeNewswire)
Oct-31-25 09:55AM	Wall Street Analysts Predict a 64.86% Upside in MiMedx (MDXG): Here's What You Should Know (Zacks)
Oct-29-25 05:25PM	MiMedx (MDXG) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:23PM	MiMedx: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Record Revenue for Third Quarter 2025 (GlobeNewswire)
Oct-28-25 09:50AM	Earnings To Watch: MiMedx Group Inc (MDXG) Reports Q3 2025 Result (GuruFocus.com)
Oct-15-25 08:00AM	MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29 (GlobeNewswire)
Oct-06-25 09:28AM	MIMEDX Announces Launch of EPIXPRESS (GlobeNewswire)
Sep-03-25 08:00AM	MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall (GlobeNewswire)
Aug-29-25 05:11AM	MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy (Insider Monkey)
Aug-27-25 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-31-25 03:32AM	MiMedx Group Inc (MDXG) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) +10.28%
Jul-30-25 05:40PM	MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:50PM	MiMedx: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results (GlobeNewswire)
08:00AM	MIMEDX Announces Strategic Collaboration with Vaporox, Inc. (GlobeNewswire)
Jul-29-25 09:50AM	What To Expect From MiMedx Group Inc (MDXG) Q2 2025 Earnings (GuruFocus.com)
Jul-16-25 09:15AM	Northland sees key positive for MiMedx in CMS rule proposal (TipRanks) +6.00%
08:00AM	MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30 (GlobeNewswire)
Jul-15-25 09:15AM	MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026 (GlobeNewswire) -6.91%
Jul-14-25 05:22PM	MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending (Investing.com)
Jul-09-25 09:36AM	Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength? (Zacks)
May-27-25 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-14-25 06:00AM	Insiders Pour $1 Million Each into These 2 Strong Buy Stocks Heres Why You Might Want to Follow Their Lead (TipRanks)
May-06-25 08:00AM	MIMEDX to Present at the BofA Securities 2025 Healthcare Conference (GlobeNewswire)
May-05-25 08:30AM	MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS) (GlobeNewswire)
May-01-25 11:03AM	Q1 2025 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents) -8.14%
03:18AM	MiMedx Group Inc (MDXG) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Apr-30-25 09:52PM	MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:15PM	MiMedx (MDXG) Q1 Earnings Match Estimates (Zacks)
04:19PM	MiMedx: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces First Quarter 2025 Operating and Financial Results (GlobeNewswire)
Apr-16-25 08:00AM	MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30 (GlobeNewswire)
Apr-10-25 04:01PM	MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences (GlobeNewswire)
Mar-31-25 05:45PM	BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Mar-20-25 01:58AM	Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.7% Jump Turn into More Strength? (Zacks)
Feb-27-25 08:22AM	Q4 2024 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
08:00AM	MIMEDX to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
02:22AM	MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-26-25 05:55PM	MiMedx (MDXG) Q4 Earnings Meet Estimates (Zacks)
05:04PM	MiMedx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results (GlobeNewswire)
Feb-25-25 10:37AM	Earnings To Watch: MiMedx Group Inc (MDXG) Reports Q4 2024 Result (GuruFocus.com)
Feb-05-25 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26 (GlobeNewswire)
Dec-17-24 09:00AM	MIMEDX Files Patent Infringement Lawsuit Against Surgenex (GlobeNewswire)
Dec-04-24 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-20-24 09:55AM	How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12% (Zacks)
Nov-14-24 09:15AM	MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs (GlobeNewswire) +23.56%
Nov-04-24 09:55AM	Can MiMedx (MDXG) Climb 77.92% to Reach the Level Wall Street Analysts Expect? (Zacks)
08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-31-24 05:00AM	MiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong International Growth and New ... (GuruFocus.com) +20.39%
Oct-30-24 05:25PM	MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
04:26PM	MiMedx: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Third Quarter 2024 Operating and Financial Results (GlobeNewswire)
Oct-14-24 08:00AM	MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 (GlobeNewswire)
Oct-09-24 03:36PM	MiMedx Group Inc (MDXG) Q2 2024 Earnings Call Highlights: Strong Sales Growth Amid Market Challenges (GuruFocus.com)
Oct-08-24 04:01PM	MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue (GlobeNewswire)
Oct-01-24 04:01PM	MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall (GlobeNewswire)
Sep-11-24 01:03PM	EX-MiMEDX EMPLOYEES ALLEGE MiMEDX 'PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS' (PR Newswire)
Sep-04-24 04:23PM	THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES' (PR Newswire)
Aug-27-24 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-26-24 09:30AM	DEFENDANT FIGHTS BACK AGAINST MiMEDX 'BLATANT INTIMIDATION' NON-COMPETE SUIT (PR Newswire)
Jul-31-24 04:22PM	MiMedx: Q2 Earnings Snapshot (Associated Press Finance) -10.34%
04:02PM	MIMEDX Announces Launch of HELIOGEN Fibrillar Collagen Matrix (GlobeNewswire)

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

CEO & DirectorMr. Joseph H. Capper

Chief Financial OfficerMr. Douglas C. Rice CPA

General Counsel & Chief Administrative OfficerMr. William F. Hulse IV

Chief Commercial OfficerMs. Kimberly Maersk-Moller

SVP of R&D & Medical Affairs and Chief Scientific OfficerDr. John Harper Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maersk-Moller Kimberly	Chief Commercial Officer	Mar 10 '26	Option Exercise	4.50	42,845	192,802	357,482	Mar 12 05:37 PM
Hulse William Frank IV	General Counsel and CAO	Mar 10 '26	Option Exercise	4.50	136,364	613,638	624,900	Mar 12 05:35 PM
DOUG RICE	Chief Financial Officer	Mar 10 '26	Option Exercise	4.50	243,000	1,093,500	508,678	Mar 12 05:34 PM
Maersk-Moller Kimberly	Chief Commercial Officer	Nov 06 '25	Sale	7.42	58,300	432,329	236,982	Nov 10 05:14 PM
Kimberly Ann Maersk-Moller	Officer	Nov 06 '25	Proposed Sale	7.33	68,587	502,743		Nov 06 04:14 PM

TELA

TELA Bio Inc

MDXG

Mimedx Group Inc

Upgrade your Finviz experience